Terri B. Hyde - Concepedia

Author

Terri B. Hyde

Centers for Disease Control and Prevention

Also Known As

Mark Gershman, T. Hyde, T.B. Hyde, Terri B Hyde, Terri B. Hyde, Terri Hyde, Terri B. Hyde

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Epidemic Intelligence Service Emory University Center for Global Health

About

Terri B. Hyde is an author at Centers for Disease Control and Prevention specializing in medicine, vaccination, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.1K
2	Epidemiology	14	14	769
3	Public Health	12	12	618
4	Health Sciences	1	1	73
5	Allergy	1	1	13

Terri B. Hyde

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Macrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates Terri B. Hyde JAMA	2001	316
Trends in Incidence and Antimicrobial Resistance of Early-Onset Sepsis: Population-Based Surveillance in San Francisco and Atlanta Terri B. Hyde, Tami M. Hilger, Arthur Reingold, PEDIATRICS	2002	190
Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine — Worldwide, 2016 Lee M. Hampton, Margaret Farrell, Alejandro Ramirez-Gonzalez, MMWR Morbidity and Mortality Weekly Report VaccinationVaccine SafetyCell-based Vaccine ProductionTrivalent OpvInfectious Disease Prevention	2016	188
Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016 James D. Heffelfinger, Xi Li, Batmunkh Nyambat, MMWR Morbidity and Mortality Weekly Report Immunization — AsiaWorld Health OrganizationDisease OutbreakJapanese Encephalitis SurveillanceFlu Vaccination	2017	155
Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Final Report Rebecca M. Casey, Jennifer B. Harris, Steve Ahuka‐Mundeke, New England Journal of Medicine	2018	138
Laboratory Characterization of Measles Virus Infection in Previously Vaccinated and Unvaccinated Individuals Carole J. Hickman, Terri B. Hyde, Sun B. Sowers, The Journal of Infectious Diseases VaccinationPreviously VaccinatedVaccine DevelopmentMeasles Virus InfectionVaccine Target	2011	135
Adverse and Beneficial Secondary Effects of Mass Treatment with Azithromycin to Eliminate Blindness Due to Trachoma in Nepal Alicia M. Fry, Hem Chandra Jha, Tom Lietman, Clinical Infectious Diseases	2002	127
Impact of a Conjugate Vaccine on Community‐Wide Carriage of Nonsusceptible<i>Streptococcus pneumoniae</i>in Alaska Matthew R. Moore, Terri B. Hyde, Thomas W. Hennessy, The Journal of Infectious Diseases	2004	126
Seroprevalence of Measles Antibody in the US Population, 1999–2004 Geraldine M. McQuillan, Deanna Kruszon‐Moran, Terri B. Hyde, The Journal of Infectious Diseases	2007	80
Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011 Kashmira Date, Andrea Vicari, Terri B. Hyde, Emerging infectious diseases VaccinationVaccine SafetyInfectious Disease EpidemiologyInfectious Disease ModellingMucosal Vaccination	2011	79

Page 1